Investigating a new anti-inflammatory compound derived from tryptophan
Biochemical and functional characterization of a novel anti-inflammatory biogenic amine
This study is looking at a new substance called 3HKA, made from tryptophan, to see how it helps control inflammation in the immune system, which could lead to new treatments for autoimmune conditions like psoriasis and lupus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10881942 on NIH RePORTER |
What this research studies
This research focuses on a novel biogenic amine called 3HKA, which is produced from the metabolism of tryptophan. The study aims to understand how 3HKA functions in regulating the immune system, particularly its anti-inflammatory effects on immune cells. Researchers will conduct biochemical and biophysical analyses to identify the enzymes involved in 3HKA production and explore its potential therapeutic benefits in conditions like psoriasis and lupus. By examining its effects on inflammation and immune response, this research seeks to uncover new treatment avenues for autoimmune diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from autoimmune diseases such as psoriasis or lupus.
Not a fit: Patients with non-autoimmune inflammatory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for autoimmune diseases by harnessing the anti-inflammatory properties of 3HKA.
How similar studies have performed: Previous research has shown promise in using metabolic pathways for immune regulation, suggesting potential success for this novel approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Santambrogio, Laura — Weill Medical Coll of Cornell Univ
- Study coordinator: Santambrogio, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.